CeQur Raises $100M Series C+

CeQur raised $100M in a late-stage round announced on June 9, 2026. CeQur is a medical device company that develops and manufactures wearable, injection-free insulin delivery solutions for people with diabetes.

Round size
$100M
Stage
Series C+
Headquarters
Switzerland
Announced
Jun 9, 2026

The company

CeQur is a medical device company that develops and manufactures wearable, injection-free insulin delivery solutions for people with diabetes.

The funding

CeQur, based in Horw, Switzerland, announced $100M in late-stage financing on June 9, 2026.

Where the funding goes

    Sources

    1. Tech.eu Funding Explorer
    03 / Related rounds

    Related funding rounds

    01
    Series C+ · Robotics

    Neura Robotics

    NEURA Robotics is a German high-tech company founded in 2019 in Metzingen near Stuttgart with the vision to revolutionize the world of robotics.

    $1.4B
    02
    Series C+ · Fintech

    Alan

    A health partner that provides insurance, prevention, and support services for individuals, independent workers, and companies.

    €480M
    03
    Series C+ · Space

    Iceye

    Company which specializes in synthetic aperture radar (SAR) satellite operations for Earth Observation.

    Led by General Atlantic
    €450M